Metformin: A Candidate Drug for Renal Diseases

Over the past decades metformin has been the optimal first-line treatment for type 2 diabetes mellitus (T2DM). Only in the last few years, it has become increasingly clear that metformin exerts benign pleiotropic actions beyond its prescribed use and ongoing investigations focus on a putative benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Corremans, Raphaëlle, Vervaet, Benjamin A., D’Haese, Patrick C., Neven, Ellen, Verhulst, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337137/
https://www.ncbi.nlm.nih.gov/pubmed/30583483
http://dx.doi.org/10.3390/ijms20010042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337137/
https://www.ncbi.nlm.nih.gov/pubmed/30583483
http://dx.doi.org/10.3390/ijms20010042

Ejemplares similares